EA199900836A1 - Противосудорожные производные изохинолилбензамида - Google Patents

Противосудорожные производные изохинолилбензамида

Info

Publication number
EA199900836A1
EA199900836A1 EA199900836A EA199900836A EA199900836A1 EA 199900836 A1 EA199900836 A1 EA 199900836A1 EA 199900836 A EA199900836 A EA 199900836A EA 199900836 A EA199900836 A EA 199900836A EA 199900836 A1 EA199900836 A1 EA 199900836A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
groups
hydrogen
6alko
cfco
Prior art date
Application number
EA199900836A
Other languages
English (en)
Inventor
Джон Дэвид Харлинг
Барри Сидни Орлек
Мервин Томпсон
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9705620.4A external-priority patent/GB9705620D0/en
Priority claimed from GBGB9726660.5A external-priority patent/GB9726660D0/en
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA199900836A1 publication Critical patent/EA199900836A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Соединения формулы (I) и их фармацевтически приемлемые солигде Rпредставляет водород, Cалкил (необязательно замещенный группой гидрокси или Cалкокси), Cалкенил, Cалкинил, C-алкилCO-, формил, CFCO- или CалкилSO-; Rпредставляет водород или до трех заместителей, выбранных из групп галоген, NO, CN, N, CFO-, CFS-, CFCO-, трифторметилдиазиринил, Cалкил, Cалкенил, Cалкинил, Cперфторалкил, Cциклоалкил, C-циалоалкил-Cалкил-, CалкилO-, CалкилCO-, Cцикло-алкилO-, CциклоалкилCO-, Cциклоалкил-CалкилO-, Cциклоалкил-CалкилCO-, фенил, фенокси, бензилокси, бензоил, фенил-Cалкил-, CалкилS-, CалкилSO-, (Cалкил)NSO-, (C-алкил)NHSO-, (Cалкил)HCO-, (Cалкил)NHCO- или CONH; или группу -NRR, где R- водород или Cалкил, а R- водород, Cалкил, формил, -COCалкил или -COCалкил; или две группы Rвместе образуют карбоциклическое кольцо, насыщенное или ненасыщенное и незамещенное или замещенное группой -OH или =O; и две группы Rи две группы R, каждая независимо, представляют собой водород или Cалкил, либо две группы Rи/или две группы Rвместе образуют Cспироалкильную группу при условии, что, по меньшей мере, одна из групп Rи Rне представляет собой водород, могут быть использованы для лечения и профилактики эпилепсии и других расстройств.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900836A 1997-03-18 1998-03-16 Противосудорожные производные изохинолилбензамида EA199900836A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9705620.4A GB9705620D0 (en) 1997-03-18 1997-03-18 Novel compounds
GBGB9726660.5A GB9726660D0 (en) 1997-12-17 1997-12-17 Novel compounds
PCT/GB1998/000781 WO1998041507A1 (en) 1997-03-18 1998-03-16 Anti-convulsant isoquinolyl-benzamide derivatives

Publications (1)

Publication Number Publication Date
EA199900836A1 true EA199900836A1 (ru) 2000-04-24

Family

ID=26311216

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900836A EA199900836A1 (ru) 1997-03-18 1998-03-16 Противосудорожные производные изохинолилбензамида

Country Status (26)

Country Link
US (1) US6277861B1 (ru)
EP (1) EP0971897A1 (ru)
JP (1) JP2001516357A (ru)
KR (1) KR20000076343A (ru)
CN (1) CN1255917A (ru)
AP (1) AP9901635A0 (ru)
AR (1) AR012078A1 (ru)
AU (1) AU732162B2 (ru)
BG (1) BG103807A (ru)
BR (1) BR9809048A (ru)
CA (1) CA2283682A1 (ru)
CO (1) CO4950554A1 (ru)
DZ (1) DZ2446A1 (ru)
EA (1) EA199900836A1 (ru)
ID (1) ID22730A (ru)
IL (1) IL131958A0 (ru)
MA (1) MA24499A1 (ru)
NO (1) NO313753B1 (ru)
NZ (1) NZ337579A (ru)
OA (1) OA11390A (ru)
PE (1) PE62199A1 (ru)
PL (1) PL335675A1 (ru)
SK (1) SK126799A3 (ru)
TR (1) TR199902282T2 (ru)
TW (1) TW509679B (ru)
WO (1) WO1998041507A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9512298A (en) * 1997-09-30 1999-04-23 Molecular Design International, Inc. Beta3-adrenoreceptor agonists, agonist compositions and methods of using
GB9817424D0 (en) * 1998-08-11 1998-10-07 Smithkline Beecham Plc Novel compounds
GB9915589D0 (en) 1999-07-02 1999-09-01 Smithkline Beecham Plc Novel compounds
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
CN109608325A (zh) * 2018-12-27 2019-04-12 先尼科化工(上海)有限公司 一种卤代苯甲酸衍生物的工业化合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
WO1988003137A1 (en) * 1986-10-28 1988-05-05 Smith Kline & French Laboratories Limited Tetrahydroisoquinolin-2-yl derivatives of carboxylic acids as thromboxane a2 antagonists
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4883593A (en) * 1988-10-27 1989-11-28 Bend Research, Inc. Ultrathin-skinned asymmetric membranes by immiscible solvents treatment
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
WO1997048683A1 (en) * 1996-06-17 1997-12-24 Smithkline Beecham Plc Substituted benzamide derivatives and their use as anticonvulsants

Also Published As

Publication number Publication date
CN1255917A (zh) 2000-06-07
IL131958A0 (en) 2001-03-19
PL335675A1 (en) 2000-05-08
BR9809048A (pt) 2000-08-01
SK126799A3 (en) 2000-05-16
AU6412798A (en) 1998-10-12
CA2283682A1 (en) 1998-09-24
WO1998041507A1 (en) 1998-09-24
OA11390A (en) 2004-04-14
TW509679B (en) 2002-11-11
PE62199A1 (es) 1999-09-10
AU732162B2 (en) 2001-04-12
MA24499A1 (fr) 1998-10-01
DZ2446A1 (fr) 2003-01-11
TR199902282T2 (en) 2000-07-21
AR012078A1 (es) 2000-09-27
EP0971897A1 (en) 2000-01-19
CO4950554A1 (es) 2000-09-01
NO994504D0 (no) 1999-09-17
BG103807A (bg) 2001-05-31
JP2001516357A (ja) 2001-09-25
ID22730A (id) 1999-12-09
NO994504L (no) 1999-09-17
NZ337579A (en) 2001-04-27
NO313753B1 (no) 2002-11-25
US6277861B1 (en) 2001-08-21
AP9901635A0 (en) 1999-09-30
KR20000076343A (ko) 2000-12-26

Similar Documents

Publication Publication Date Title
EA200200873A1 (ru) Новые пиперазиновые производные
ES541372A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
EA199800923A1 (ru) Новые 2,3-двузамещенные 4(3н)-хиназолины
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
PT96001A (pt) Processo para a preparacao de derivados de isoquinolina condensada com um anel carbociclico
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
BG60431B1 (bg) Производни на бензоксазол- и бензотиазоламини
SE8600413L (sv) Nytt lekemedel och sett att framstella detsamma
MX9204622A (es) Nuevos derivados de 3,5-di-tert-butil-4-hidroxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2145743T3 (es) Compuesto de anillo condensado benzoxa, su produccion y composicion farmaceutica que lo contiene.
DE3873007T2 (de) Kathartica.
EA199900836A1 (ru) Противосудорожные производные изохинолилбензамида
NO942568D0 (no) 1-aryloksy-3-alkylamino-2-propanolitratestere, deres anvendelse og tilsvarende farmasöytiske blanding
EA200001184A1 (ru) Фенилсульфонамидфенилэтиламины, полезные в качестве допаминовых рецепторов
DK0482084T3 (da) (1,2N)- og (3,2N)-carbocyklisk-2-amino-tetralin-derivater.
ES522418A0 (es) Un procedimiento para preparar -15-desoxiespergualina.
ATE41145T1 (de) Antikonvulsiermittel.
ES509782A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol y etanodiol.
DE3878967D1 (de) 17-aza-20,21-dinoreburnameninderivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
EA200100033A1 (ru) Тетрагидронафтиридинил-карбоксамиды, обладающие противосудорожной активностью
ATE33980T1 (de) Benzaldoxim-carbamat-derivate.
FI912501A0 (fi) Foerfarande foer framstaellning av optiskt aktivt cyklobutanon, vilken aer en mellanprodukt vid framstaellningen av optiskt aktiv cyklobutannukleosid.
PT98186A (pt) Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem
BE905154A (fr) Acides n-nicotinoylamines.
ES2141134T3 (es) Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares.